Stock listing

NBIX Stock Price, News, Filings & Events — Neurocrine Biosciences, Inc.

Selected listing: NBIX · BMV · MXN · MX

NBIX:BMV is the public listing for Neurocrine Biosciences, Inc., a U.S.-based company specializing in innovative therapies for neurological and endocrine disorders. With a market capitalization of around $17.18 billion, Neurocrine is focused on developing treatments that enhance patient outcomes. The company is actively engaged in addressing unmet medical needs within its sector, reflecting its commitment to advancing healthcare solutions. Recent news and filings may provide further insights into its ongoing projects and market activities.

NBIX:BMVMXNMXUpdated July 24, 2026
Neurocrine Biosciences, Inc. logo
Ticker
NBIX:BMV
Asset type
Stock
Market cap
$17.67B
Sector
Health Technology
Industry
Biotechnology
Exchange
BMV
Currency
MXN

Neurocrine Biosciences, Inc. NBIX:BMV stock context

NBIX:BMV is the public listing for Neurocrine Biosciences, Inc., a U.S.-based company specializing in innovative therapies for neurological and endocrine disorders. With a market capitalization of around $17.18 billion, Neurocrine is focused on developing treatments that enhance patient outcomes. The company is actively engaged in addressing unmet medical needs within its sector, reflecting its commitment to advancing healthcare solutions. Recent news and filings may provide further insights into its ongoing projects and market activities.

Research Neurocrine Biosciences, Inc.

Alternate listings